All In MedTech

Device Trial Radar · NCT05873582

Robotic Minimally Invasive Inguinal Hernia Repair With Dexter

Last checked: Nov 19, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

50

Actual

Start

Jun 2, 2023

Primary completion

Oct 23, 2023

Study completion Oct 23, 2023

Sponsor

Lead sponsor
Distalmotion SANot on our public-company list
Sponsor type
Industry
Collaborators
Confinis
First posted
May 24, 2023

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
All sexes, from 18 years

Summary

As written by the sponsor on the registry.

This study aims to confirm the perioperative and early postoperative safety and clinical performance (efficacy) of the Dexter Robotic System, in patients undergoing primary transperitoneal unilateral or bilateral inguinal hernia repair.

Conditions

  • Inguinal Hernia Repair

Interventions

  • Robotic-assisted inguinal hernia repairDevice

    Primary transperitoneal unilateral or bilateral inguinal hernia repair with the Dexter robotic system

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Safety: occurrence of serious (Clavien - Dindo grades III-V), device-related, adverse eventsTime frame: perioperatively up to 30 days
  2. Performance: successful completion of the Dexter-assisted procedure, i.e. free of any conversion to an open or fully laparoscopic surgical approachTime frame: intraoperative

Locations

3 sites in 3 countries. Site status is shown where the registry gives one.

  • Centre Hospitalier de Saintes

    Saintes, France

  • UKSH Kiel

    Kiel, Germany

  • Kantonspital Winterthur

    Winterthur, Switzerland

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.